Printer Friendly

Business briefs.


Telegram & Gazette

Bloomberg Indes

Central Massachusetts

- 2.38


Volume: 89,175,746

Up: 6

Down: 17

Unchanged: 6

Gainer: Waters Corp. $79.71 +$1.43 (Volume of 1.56 million shares)

Decliner: Virtusa Corp. $14.39 -$2.07 (Volume of 24,279 shares)


McGuire named

WORCESTER - Antonia G. McGuire of Westboro has been named president and chief executive officer of Great Brook Valley Health Center Inc. effective Feb. 1. She replaces Zoila Torres Feldman, who stepped down last year.

The health center provides primary care, mental health services and dental care services to 24,000 annually with offices in Worcester, Clinton and Framingham. Ms. McGuire, a registered nurse with a master's degree in public health, is CEO of Manet Community Health Center in Quincy. She was formerly director of administration and community affairs in the department of family medicine at Boston Medical Center. From 1996 to 1997 she was system director for health education and promotion at Fallon Healthcare System.


Wal-Mart hearing

LEICESTER - The state Division of Banks will conduct a public hearing at 6 p.m. Jan. 23 at Leicester Town Hall, 3 Washburn Square, to consider a check casher license for Wal-Mart Stores Inc. Wal-Mart operates a store at 1620 Main St. (Route 9) in Leicester.

Stem cell grant

ALAMEDA, Calif. - Advanced Cell Technology Inc., which has operations in Worcester, has received a business innovation research grant from the National Institutes of Health. The grant, whose amount was not disclosed, will fund research involving labeling and purification of specific lineage restricted cells in cultures of embryonic stem cells.

Assumption class

WORCESTER - A supply chain professional certification class sponsored by APICS, the Association for Operations Management, will be held Tuesdays from 6 to 9 p.m. starting Jan. 29 at Assumption College. The registration fee is $20 and the deadline to enroll is Jan. 22. More information is available at

Agreement ends

NATICK - Osiris Therapeutics Inc. ended a research collaboration with Boston Scientific Corp. for developing the experimental stem-cell treatment Prochymal.

Osiris, based in Columbia, Md., will cancel a $50 million credit line from Boston Scientific and will repay the company $50 million in development funds and a $5 million loan.

Separately, Boston Scientific reported it had completed the sale of its cardiac surgery and vascular surgery businesses to Getinge Group of Sweden for $750 million in cash. Boston Scientific has operations in Marlboro. (Bloomberg News)


CUTLINE: Ms. McGuire
COPYRIGHT 2008 Worcester Telegram & Gazette
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:BUSINESS
Publication:Telegram & Gazette (Worcester, MA)
Date:Jan 9, 2008
Previous Article:Jordan scores 1,000th in win.
Next Article:Judge merges racketeering lawsuits; Defendants include `Duddie' Massad.

Related Articles
Business briefs.
Business briefs.
Business briefs.
Business briefs.
Business briefs.
Business briefs.
Business briefs.
Business briefs.
Business briefs.
Business briefs.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters